Skip to main content
. 2022 Oct 20;12:04092. doi: 10.7189/jogh.12.04092

Table 3.

Prevalence of sleep disorders and associated comorbidities

Heterogeneity
Sleep disorders
n
Prevalence (95% CI)
N
I2
τ2
P
SWD
5
31% (15%-53%)
9117
99%
1.0802
<0.01
OSA
13
30% (18%-46%)
70 687
100%
1.5367
<0.0001
Insomnia
15
28% (19%-39%)
38 518
100%
1.2234
<0.0001
EDS
14
28% (24%-33%)
7905
96%
0.1715
<0.01
RLS
2
2% (1%-4%)
11 231
97%
0.1347
<0.01
Narcolepsy
2
1% (0%-5%)
4434
95%
1.1393
<0.01
Associated comorbidities

OR (95% CI)
N
I2
τ2
P
OSA






Anxiety
2
2.46 (1.99-3.03)
11 890
0%
0.0000
0.447
CVD
2
2.03 (1.43-2.88)
11 890
0%
0.0000
0.896
DM
2
1.91 (1.41-2.65)
11 890
0%
0.0000
0.689
Depression
4
1.89 (1.01-3.56)
63 640
97%
0.3870
<0.0001
GERD
6
1.83 (1.50-2.22)
11 150
48%
0.0220
0.084
PTSD
2
1.78 (1.33-2.39)
5557
42%
0.0240
0.188
Insomnia






Depression
2
9.74 (4.67-20.3)
10 955
93%
0.3910
<0.0001
Anxiety
2
9.22 (3.81-22.3)
10 955
94%
0.5720
<0.0001
PTSD 3 7.13 (6.27-8.10) 20 743 19% 0.0030 0.291

CI – confidence interval, CVD – cardiovascular disease, DM – diabetes mellitus, EDS – excessive daytime sleepiness, GERD – gastroesophageal reflux disease, n – number of studies, N – sample size, OR – odds ratio, OSA – obstructive sleep apnoea, PTSD – post-traumatic stress disorder, RLS – restless leg syndrome, SWD – shift work disorder